FDA Approves First Cannabis-Based Prescription Drug

The Food and Drug Administration on Monday approved the oral solution cannabis-based drug Epidiolex, which will be used to treat two forms of epilepsy in children.

While Epidiolex lacks the euphoria associated with marijuana use, it’s considered an option for patients who’ve failed to respond to other treatments to control seizures, according to U.S. health regulators.

“This approval serves as a reminder that advancing sound development programs that properly evaluate active ingredients contained in marijuana can lead to important medical therapies,” said FDA Commissioner Scott Gottlieb. “The FDA is committed to this kind of careful scientific research and drug development.

Gottlieb said Epidiolex, which will be available in the fall, is the “most appropriate way to bring marijuana-derived treatments to patients.”

Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Back to top button

My News Matters to me - Washington Informer Donations

Be a Part of The Washington Informer Legacy

A donation of your choice empowers our journalists to continue the work to better inform, educate and empower you through technology and resources that you use.

Click Here Today to Support Black Press and be a part of the Legacy!

Adblock Detected

Please consider supporting us by disabling your ad blocker